Shinn-Zong Lin Selected Research

Levodopa (L Dopa)

1/2022	Effect of deep brain stimulation on brain network and white matter integrity in Parkinson's disease.
1/2011	Targeting the subthalamic nucleus for deep brain stimulation--a comparative study between magnetic resonance images alone and fusion with computed tomographic images.
1/2009	Prognostic factors of subthalamic stimulation in Parkinson's disease: a comparative study between short- and long-term effects.
9/2007	5,10-methylenetetrahydrofolate reductase C677T gene polymorphism can influence age at onset of Parkinson's disease.
1/2007	Genetic polymorphism of the angiotensin converting enzyme and L-dopa-induced adverse effects in Parkinson's disease.
5/2005	Early-onset Parkinson's disease in a Chinese population: 99mTc-TRODAT-1 SPECT, Parkin gene analysis and clinical study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shinn-Zong Lin Research Topics

Disease

47	Neoplasms (Cancer) 12/2023 - 02/2002
29	Parkinson Disease (Parkinson's Disease) 10/2022 - 07/2002
28	Stroke (Strokes) 11/2022 - 02/2003
18	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 05/2005
16	Infarction (Infarctions) 11/2020 - 05/2003
14	Fibrosis (Cirrhosis) 12/2023 - 01/2014
12	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2023 - 06/2007
12	Ischemia 11/2022 - 02/2003
12	Brain Neoplasms (Brain Tumor) 01/2022 - 02/2002
11	Myocardial Infarction 12/2021 - 01/2013
9	Lung Neoplasms (Lung Cancer) 12/2022 - 09/2003
9	Brain Ischemia (Cerebral Ischemia) 03/2016 - 08/2004
8	Inflammation (Inflammations) 12/2023 - 01/2016
8	Liver Cirrhosis (Hepatic Cirrhosis) 12/2019 - 09/2009
7	Machado-Joseph Disease (Spinocerebellar Ataxia Type 3) 12/2023 - 01/2014
7	Glioma (Gliomas) 02/2022 - 02/2002
7	Hypoxia (Hypoxemia) 04/2015 - 09/2005
6	Ischemic Stroke 01/2022 - 03/2006
4	Carcinogenesis 01/2023 - 01/2011
4	Traumatic Brain Injuries (Traumatic Brain Injury) 11/2022 - 01/2014
4	Cardiovascular Diseases (Cardiovascular Disease) 10/2018 - 01/2007
4	Wounds and Injuries (Trauma) 01/2018 - 07/2004
4	Prostatic Neoplasms (Prostate Cancer) 09/2013 - 04/2011
4	Cerebral Infarction 02/2008 - 08/2004
3	Neuroblastoma 09/2022 - 04/2004
3	Obesity 12/2021 - 10/2020
3	Dementia (Dementias) 10/2021 - 01/2014
3	Alzheimer Disease (Alzheimer's Disease) 03/2020 - 03/2015
3	Cardiac Arrhythmias (Arrythmia) 05/2016 - 04/2012
3	Huntington Disease (Huntington's Disease) 12/2015 - 07/2002
3	Hypersensitivity (Allergy) 01/2015 - 01/2013
3	Dyskinesias (Dyskinesia) 10/2013 - 01/2007
2	Heart Failure 12/2023 - 01/2013
2	Mitochondrial Diseases (Mitochondrial Disease) 12/2023 - 10/2023
2	Infections 07/2023 - 01/2022
2	COVID-19 07/2023 - 12/2022
2	Cardiomegaly (Heart Hypertrophy) 01/2023 - 10/2019
2	Hyperlipidemias (Hyperlipidemia) 01/2023 - 01/2018
2	Hydrocephalus (Hydrocephaly) 01/2023 - 11/2010
2	Disease Progression 12/2022 - 04/2020
2	Down Syndrome (Down's Syndrome) 09/2022 - 03/2015

Drug/Important Bio-Agent (IBA)

30	butylidenephthalideIBA 09/2022 - 11/2006
17	Proteins (Proteins, Gene)FDA Link 12/2023 - 08/2004
10	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2021 - 09/2004
7	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2023 - 12/2014
7	Therapeutic UsesIBA 07/2023 - 01/2015
7	isochaihulactoneIBA 01/2018 - 07/2006
6	CytokinesIBA 08/2023 - 01/2009
6	Superoxides (Superoxide)IBA 08/2022 - 02/2015
6	Levodopa (L Dopa)FDA LinkGeneric 01/2022 - 05/2005
5	Prion ProteinsIBA 08/2013 - 04/2004
4	AntioxidantsIBA 12/2023 - 01/2017
4	PolymersIBA 02/2022 - 06/2011
4	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2021 - 09/2003
4	MicroRNAs (MicroRNA)IBA 04/2018 - 01/2011
4	Neuroprotective AgentsIBA 01/2018 - 09/2005
4	Nerve Growth Factor (NGF)IBA 01/2018 - 12/2014
4	Messenger RNA (mRNA)IBA 01/2018 - 05/2006
4	Thioacetamide (Thioacetamid)IBA 01/2017 - 01/2010
4	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 07/2008
4	AcetoneIBA 07/2006 - 09/2003
3	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2023 - 01/2023
3	polyglutamineIBA 12/2023 - 01/2014
3	Herbal TeasIBA 07/2023 - 01/2022
3	LipopolysaccharidesIBA 07/2023 - 01/2015
3	Transcription Factors (Transcription Factor)IBA 11/2022 - 09/2005
3	Temozolomide (Temodar)FDA LinkGeneric 01/2022 - 07/2019
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2019
3	SynucleinsIBA 09/2021 - 01/2014
3	Small Interfering RNA (siRNA)IBA 01/2019 - 01/2012
3	CollagenIBA 10/2018 - 01/2010
3	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2018 - 07/2015
3	3-nitrotyrosineIBA 01/2018 - 02/2015
3	LithiumIBA 01/2017 - 12/2014
3	Oxygen (Dioxygen)IBA 01/2017 - 04/2004
3	Metalloproteases (Metalloproteinases)IBA 01/2016 - 01/2010
3	erucylphosphocholineIBA 08/2014 - 01/2007
3	Matrix Metalloproteinases (MMPs)IBA 10/2013 - 09/2009
3	Chemokine CXCL12IBA 12/2009 - 02/2008
3	Chloroform (Trichloromethane)IBA 10/2008 - 05/2005
3	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2007 - 07/2002
2	Liposomes (Liposome)IBA 12/2023 - 06/2020
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 08/2023 - 01/2019
2	LipidsIBA 01/2023 - 07/2021
2	peiminineIBA 01/2023 - 09/2021
2	EstersIBA 01/2023 - 01/2023
2	inerminIBA 08/2022 - 06/2020

Therapy/Procedure

48	Therapeutics 12/2023 - 05/2003
18	Transplantation 11/2022 - 01/2006
12	Deep Brain Stimulation 01/2022 - 03/2006
6	Drug Therapy (Chemotherapy) 12/2023 - 08/2008
6	Hysterectomy 01/2021 - 01/2018
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2023 - 05/2005
3	Acupuncture Therapy 11/2022 - 01/2014
3	Ovariectomy (Oophorectomy) 01/2021 - 01/2018
3	Liver Transplantation 12/2019 - 01/2013
3	Immunotherapy 05/2012 - 01/2009
3	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2009 - 01/2006
2	Intranasal Administration 12/2023 - 01/2019
2	Ventriculoperitoneal Shunt 01/2023 - 11/2010